(주)메타신기업정보

Metacine, Inc. is a research-oriented venture enterprise certified with evaluation based on technology guarantee and credit investigation by Korea Technology Finance Corporation (KOTEC) since 2010.

1. 유방암으로부터의 여성 해방을 통한 가정 행복 추구 2. 인류의 뼈 건강을 소중히 생각하는 기업 육성 3. 그 가치관 실현에 걸맞은 인력 양성
Metacine Healthcare R&D is for discovering biopharmaceutical materials to provide in two ways of protein or chemical compound drugs and health functional foods to prevent and/or treat bone destruction caused by breast cancer bone metastasis or osteoporosis (patents, 2012 & pending in Korea, 2016; patents in USA, 2016). Manufacturing of a beauty & treatment device, Laskinall®, is for an another business. This tool is a highly effective, rigorously laser-based aesthetic resurfacing provider (patent in Korea, 2015), offering ideal performance yet balanced for customer's skincare goals. This convergence product is supplied with cosmetics made from Korean natural resources in liquid. In addition, rhinitis treatment device, Lasrhina®, is also developed. As a part of global business strategy, Metacine, Inc. plans to found a new business company in Europe by 2021.